Differential Expression of CD163 on Monocyte Subsets in Healthy and HIV-1 Infected Individuals
2011

CD163 Expression on Monocyte Subsets in Healthy and HIV-1 Infected Individuals

Sample size: 38 publication 10 minutes Evidence: moderate

Author Information

Author(s): Emma Tippett, Wan-Jung Cheng, Clare Westhorpe, Paul U. Cameron, Bruce J. Brew, Sharon R. Lewin, Anthony Jaworowski, Suzanne M. Crowe

Primary Institution: Centre for Virology, The Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne, Victoria, Australia

Hypothesis

CD163 expression on monocyte subsets may serve as a biomarker for HIV-1 disease progression and inflammation.

Conclusion

The study found that CD163 expression is higher on certain monocyte subsets in HIV-1 infected individuals compared to healthy controls, suggesting its potential role in monitoring inflammation.

Supporting Evidence

  • CD163 expression was significantly higher on CD14++CD16+ monocytes in HIV-1 infected donors compared to uninfected donors.
  • CD163 expression on CD14++CD16− monocytes was also higher in HIV-1 infected individuals, although not statistically significant.
  • The study utilized whole blood immunophenotyping to assess CD163 expression levels.

Takeaway

This study looked at a special marker called CD163 on different types of blood cells in people with and without HIV. They found that people with HIV had more of this marker on some cells, which might help doctors understand how the disease affects the body.

Methodology

The study used flow cytometry to analyze CD163 expression on monocyte subsets from blood samples of HIV-1 infected and uninfected individuals.

Potential Biases

Potential biases may arise from the selection of participants and the methods used for blood sample processing.

Limitations

The study's findings may be influenced by the small sample size of certain groups and the variability in CD163 expression due to sample handling.

Participant Demographics

Participants included 38 HIV-1 infected individuals and 26 age-matched healthy controls.

Statistical Information

P-Value

0.021

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0019968

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication